(Q24201550)

English

Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

0 references

0 references

Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item (English)

0 references

0 references

1 reference

1

Lisa A Bero

Lisa A

Bero

1 reference

stated in

PubMed

PubMed publication ID

24575439

retrieved

21 October 2023

language of work or name

1 reference

20 December 2013

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Industry sponsorship and research outcome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.ED000075

retrieved

21 January 2018

Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.ED000075

retrieved

21 January 2018

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.ED000075

retrieved

21 January 2018

The cycle of bias in health research: a framework and toolbox for critical appraisal training

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.ED000075

retrieved

21 January 2018

Design and reporting modifications in industry-sponsored comparative psychopharmacology trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.ED000075

retrieved

21 January 2018

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.ED000075

retrieved

21 January 2018

Outcome reporting in industry-sponsored trials of gabapentin for off-label use

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.ED000075

retrieved

21 January 2018

Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.ED000075

retrieved

21 January 2018

Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study

(Q24201550)

Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)